University of Phoenix Celebrates National Nurses Week: Healthcare Workers in 2025 Meeting Challenges with Optimism
PHOENIX--(BUSINESS WIRE)--In honor of National Nurses Week (May 6-12), University of Phoenix highlights the evolving role of healthcare workers, showcasing their optimism and the challenges they face. Results from the 2025 University of Phoenix Career Optimism Index® study found that healthcare workers, including nurses, are optimistic about their careers and find purpose in their work while also facing challenges in the field. According to the study, 80% of those surveyed are hopeful about the future of their careers, and 88% say the work they do is meaningful to them.
Despite this optimism, healthcare workers are slowly losing their sense of control over their careers. Just over half of workers surveyed (54%) feel in control of their professional future, and 59% report experiencing burnout at work. This lack of control significantly increases the risk of burnout.
'During National Nurses Week, we celebrate the dedication of nurses and the resilience of these real-life heroes," states Raelene Brooks, Ph.D., RN, dean, College of Nursing at University of Phoenix. "Nurses are an exceptional level of professionals with a deep desire to care for and support our patients and their families - which can be a gift and a challenge. Healthcare continues to evolve at a rapid pace and nurses not only set the pace, they rise when doing so. We must acknowledge, celebrate and applaud the vital contribution of our nurses whose skills and compassion are essential in delivering safe, quality patient care."
When asked how they expect their role to change within the next five years, healthcare workers cited the following for most anticipated changes:
Increasing involvement with information systems (43%)
Increasingly greater role in the management of overall patient care planning (40%)
Increasingly greater leadership role at their facility (36%)
As opportunities continue to increase in the profession, healthcare workers note that employers should focus on preparing healthcare professionals with greater leadership skills (87%), according to the study.
University of Phoenix alum and Vice President Health Services for The GEO Group, Inc., Jason Wright, MHA, BSN, RN, says that while nurses are operating in an increasingly complex environment, a strong educational foundation and growth mindset can help pave the way for a fulfilling career. 'As the healthcare landscape becomes more complex, continuous education and training are crucial for nurses to thrive,' he states. 'By investing in ongoing education and professional development, we can empower nurses to adapt to new challenges and excel in their roles.'
University of Phoenix College of Nursing recognizes that flexible and relevant educational programs are essential to prepare students for contemporary nursing practice. Nursing students with the College will encounter teaching and learning strategies that encourage progression as well as online options including the availability of:
Two RN to Bachelor of Science (BSN) in Nursing programs, (one being competency-based
Master of Science in Nursing (MSN) with five concentrations to choose from
Doctor of Nursing Practice (DNP)
University of Phoenix graduate Dorinda Joy Miller, RN, who completed the University of Phoenix RN to BSN Competency-based program, shared her experience, stating, "The competency-based program at University of Phoenix fit perfectly into my busy lifestyle. I am a mom of six and have been a nurse for over 25 years. The program was challenging but my instructors helped me along the way and reassured me when I had doubts.'
The College of Nursing at University of Phoenix offers students access to practitioner faculty that possess an average of 30.2 years of professional experience. The current faculty includes four chief executive officers, two chief nursing officers, and 13 Directors of Service.
Learn more here about online nursing degrees at University of Phoenix.
University of Phoenix innovates to help working adults enhance their careers and develop skills in a rapidly changing world. Flexible schedules, relevant courses, interactive learning, skills-mapped curriculum for our bachelor's and master's degree programs and a Career Services for Life® commitment help students more effectively pursue career and personal aspirations while balancing their busy lives.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
The Berwyn Group Appoints Adam Wilson as General Manager of Healthcare
Veteran Leader Brings Deep Industry Expertise to Advance Berwyn's Healthcare Strategy INDEPENDENCE, Ohio, June 13, 2025 /PRNewswire/ -- The Berwyn Group (Berwyn), the leader in death audit, locate services and population management, is pleased to announce the hiring of Adam Wilson as General Manager of Healthcare. Wilson brings extensive healthcare industry experience that will further strengthen Berwyn's commitment to excellence and growth. Berwyn offers an end-to-end suite of industry-leading death audit and locate solutions that enable pension and health plan administrators to eliminate costly overpayments, maximize efficiency, meet regulatory requirements, and connect policyholders, participants and beneficiaries to the funds they deserve. More than 2,000 corporate, union and government clients use Berwyn's flagship services, CertiDeath® and CertiCensus®. Wilson joins Berwyn with a distinguished career that spans almost 17 years at UnitedHealthcare, where he held several leadership roles including Vice President of Workforce Planning, Chief of Staff to the COO, and Vice President of Medicare Part D products. "We are thrilled to welcome Adam to the team," said John Bikus, President of Berwyn. "His strategy, proven leadership, and deep industry knowledge will be invaluable as we continue to grow in the healthcare industry." In his new role, Wilson will be responsible for leading Berwyn's strategic expansion into the healthcare market. He will be focusing on aligning Berwyn's solutions to the healthcare payer and provider business cycle needs while also extending the Berwyn reach to healthcare-related supporting partners, vendors, and industry trade groups. "I'm eager to join an organization positioned for rapid growth through industry-leading capabilities," said Wilson. "I look forward to collaborating with the talented team at Berwyn to deliver quick wins, strategic expansion into healthcare, and contribute to the company's continued success." About The Berwyn Group The Berwyn Group is the leader in population data management, offering the industry's most trusted and effective death audit and locate solutions, with an unmatched dedication to innovation, security, and generating outcomes. Acquired by Longevity Holdings in 2023, The Berwyn Group offers an end-to-end suite of industry-leading solutions including CertiDeath® Paragon™, CertiDeath®, CertiCensus®, CertiSearch® and BeneSearch®. Connecting leading-edge technology and data with best-in-class human ingenuity, Berwyn helps bridge the gap between pensions and their participants, insurance companies and their policyholders, third-party administrators and public entities with Medicaid recipients. For more information, visit Media Contact Karlene Gilmore Director of Marketing kgilmore@ View original content: SOURCE The Berwyn Group, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
4 hours ago
- Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2025. In 2005, the World Health Assembly designated June 14th as World Blood Donor Day to recognize and thank blood donors across the world for their important contributions to the global blood supply. This year's theme, 'Give blood, give hope: together we save lives' is a reminder that hope is something we can all share. Cerus is proud to promote blood safety and expand donor eligibility, helping more people give, and more people receive the transfusions they need. The Company salutes the individuals, communities, and countries working together to make blood safety and availability a reality. 'A safe and reliable blood supply remains a cornerstone of every effective healthcare system around the globe, and one that would not be possible without the countless individuals that donate their time and blood. World Blood Donor Day is an opportunity to thank these individuals and to raise public awareness of the ongoing need for additional blood donations,' said Obi Greenman, Cerus' President and Chief Executive Officer. 'I am proud that Cerus is leading the development of pathogen reduction technologies for transfused blood components to help enable our blood center customers to deliver safe and effective blood components to patients.' According to the World Health Organization (WHO), more than 118.5 million blood donations are collected annually around the world, with 40% of these donations collected in high-income countries that account for only 16% of the global population. A wide variety of patients regularly receive blood transfusion, including cardiovascular surgery, transplant surgery, massive trauma, cancer, obstetric, and childhood anemia patients. 1 In recognition of World Blood Donor Day, Cerus hosted a blood drive earlier this week at its company headquarters and encourages everyone to participate in supporting blood product availability in their local communities. 1. ABOUT CERUS Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the U.S., the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the U.S. For more information about Cerus, visit and follow us on LinkedIn. INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.
Yahoo
4 hours ago
- Yahoo
Cerus Corporation Celebrates World Blood Donor Day 2025
CONCORD, Calif., June 13, 2025--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2025. In 2005, the World Health Assembly designated June 14th as World Blood Donor Day to recognize and thank blood donors across the world for their important contributions to the global blood supply. This year's theme, "Give blood, give hope: together we save lives" is a reminder that hope is something we can all share. Cerus is proud to promote blood safety and expand donor eligibility, helping more people give, and more people receive the transfusions they need. The Company salutes the individuals, communities, and countries working together to make blood safety and availability a reality. "A safe and reliable blood supply remains a cornerstone of every effective healthcare system around the globe, and one that would not be possible without the countless individuals that donate their time and blood. World Blood Donor Day is an opportunity to thank these individuals and to raise public awareness of the ongoing need for additional blood donations," said Obi Greenman, Cerus' President and Chief Executive Officer. "I am proud that Cerus is leading the development of pathogen reduction technologies for transfused blood components to help enable our blood center customers to deliver safe and effective blood components to patients." According to the World Health Organization (WHO), more than 118.5 million blood donations are collected annually around the world, with 40% of these donations collected in high-income countries that account for only 16% of the global population. A wide variety of patients regularly receive blood transfusion, including cardiovascular surgery, transplant surgery, massive trauma, cancer, obstetric, and childhood anemia patients.1 In recognition of World Blood Donor Day, Cerus hosted a blood drive earlier this week at its company headquarters and encourages everyone to participate in supporting blood product availability in their local communities. 1. ABOUT CERUS Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the U.S., the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the U.S. For more information about Cerus, visit and follow us on LinkedIn. INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation. View source version on Contacts Tim Lee – Head of Investor RelationsCerus Corporation925-288-6128 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
